Heart Failure Research Group, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria 3004, Australia.
Department of Pharmacology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Road, Clayton Victoria 3800, Australia.
Nat Rev Cardiol. 2018 Jan;15(1):20-32. doi: 10.1038/nrcardio.2017.120. Epub 2017 Aug 24.
Hypertension is the leading risk factor for heart disease and stroke, and is estimated to cause 9.4 million deaths globally every year. The pathogenesis of hypertension is complex, but lifestyle factors such as diet are important contributors to the disease. High dietary intake of fruit and vegetables is associated with reduced blood pressure and lower cardiovascular mortality. A critical relationship between dietary intake and the composition of the gut microbiota has been described in the literature, and a growing body of evidence supports the role of the gut microbiota in the regulation of blood pressure. In this Review, we describe the mechanisms by which the gut microbiota and its metabolites, including short-chain fatty acids, trimethylamine N-oxide, and lipopolysaccharides, act on downstream cellular targets to prevent or contribute to the pathogenesis of hypertension. These effects have a direct influence on tissues such as the kidney, the endothelium, and the heart. Finally, we consider the role of the gut microbiota in resistant hypertension, the possible intergenerational effect of the gut microbiota on blood pressure regulation, and the promising therapeutic potential of gut microbiota modification to improve health and prevent disease.
高血压是心脏病和中风的主要风险因素,据估计,每年它在全球造成 940 万人死亡。高血压的发病机制很复杂,但饮食等生活方式因素是导致这种疾病的重要因素。大量摄入水果和蔬菜与降低血压和降低心血管死亡率有关。文献中描述了饮食摄入与肠道微生物组组成之间的关键关系,越来越多的证据支持肠道微生物组在调节血压方面的作用。在这篇综述中,我们描述了肠道微生物组及其代谢物(包括短链脂肪酸、三甲胺 N-氧化物和脂多糖)作用于下游细胞靶点以预防或促成高血压发病机制的机制。这些作用对肾脏、内皮和心脏等组织有直接影响。最后,我们考虑了肠道微生物组在难治性高血压中的作用、肠道微生物组对血压调节的可能代际影响,以及肠道微生物组修饰以改善健康和预防疾病的有希望的治疗潜力。